These findings are consistent with a recent preclinical trail of JAK inhibitors to treat keloids and refine the key role of IL-13RA2 and JAK/STAT6 in keloid fibrogenesis, which may inspire further translational research of keloid treatment and wound healing. The gene discussed is IL13RA2; the disease is keloid.